In a recent longitudinal analysis, four phenotypes of PD‐L1high Breg populations were notably prevalent in non‐toxic NSCLC patients treated with anti‐PD‐1/PD‐L1 through functional ex vivo and deep phenotyping mass cytometric assays.135. Here, CD274 is linked to non-small cell lung carcinoma.